Effective control of the spread of HIV depends on using the right antiretroviral drugs. In 2019, the World Health Organization recommended using the integrase inhibitor, dolutegravir (DTG), in first- ...
3TC: Lamivudine; ABC: Abacavir; DRV: Darunavir; DTG: Dolutegravir; EFV: Efavirenz; FTC: Emtricitabine; rtv: Ritonavir; TDF: Tenofovir. Enfuvirtide No interaction ...
Researchers conducted a randomized trial in seven European countries to compare the efficacy and safety of an integrase inhibitor-containing antiretroviral regimen vs a boosted protease ...
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders,* today announced data presentations from its innovative HIV treatment and prevention ...
LOS ANGELES (Reuters) - Merck & Co. Inc.'s experimental HIV drug in a new class called integrase inhibitors can control the virus in nearly 80 percent of previously treated patients, when combined ...
Three experimental injectable antiretrovirals – a novel capsid inhibitor and two next-generation integrase inhibitors – could ...
The FDA approved the first integrase inhibitor for the treatment of HIV on Oct. 12. The pharmaceutical company Merck developed the drug as raltegravir; it will be marketed under the name Isentress for ...
SAN FRANCISCO--(BUSINESS WIRE)--Exavir Therapeutics, a company dedicated to transforming the lives of patients with chronic viral infections and CNS disorders with ultra-long-acting therapeutics, ...
white pills Integrase strand transfer inhibitors (INSTIs) are a generally well-tolerated class of antiretrovirals that have a higher antiviral potency compared with other classes of ART. Integrase ...
The inhibition of HIV-1’s replicative machinery remains a cornerstone in the battle against AIDS. Central to this approach are inhibitors targeting reverse transcriptase (RT) and integrase. Reverse ...
Background. Integrase strand transfer inhibitors (INSTIs) are crucial for the treatment of human immunodeficiency virus (HIV) type 2 infection, due to limited available therapeutic options. Recently, ...